Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DARE2: Lu AF28996 in Parkinson's Disease
NCT07514858Phase 2Recruiting
- Sponsor
- Lundbeck
- Start
- Jul 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lu AF28996 in Parkinson's disease (PD), sponsored by Lundbeck. Started Jul 2026; status: recruiting.
02
Drugs
Lu AF28996
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07514858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07514858.